Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects

Journal of Law, Medicine and Ethics 37 (2):209-221 (2009)
  Copy   BIBTEX

Abstract

Tens of millions of adults and children die each year from illnesses that are treatable or preventable with existing medicines. Each year over 500 million people are infected with malaria, and the disease kills two million people annually. Hundreds of thousands more die annually from a myriad of lesser known diseases including diphtheria, measles, tetanus, and syphilis. Approximately 30 percent of the world’s population, over 1.7 billion people, has inadequate access or no access at all to essential medicines.Not surprisingly, the vast majority of these illnesses are contracted in poor countries. Four million lives could be saved annually through prompt diagnosis and treatment of illnesses in Africa and Southeast Asia alone, and access to pharmaceutical drugs could likely save millions more. Many of the health problems facing the developing world do not arise from lack of understanding of complex diseases. Rather, the problem arises from a striking lack of availability of life-saving medicines for the consumers that need these medicines the most.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 92,150

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
Montréal Statement on the Human Right to Essential Medicines.Thomas Pogge - 2007 - Cambridge Quarterly of Healthcare Ethics 16 (1):97-108.
Supply of medicines: paternalism, autonomy and reality.D. Prayle & M. Brazier - 1998 - Journal of Medical Ethics 24 (2):93-98.

Analytics

Added to PP
2015-10-24

Downloads
25 (#635,454)

6 months
7 (#436,298)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Pharmaceutical Innovation: Law & the Public's Health.Kevin Outterson - 2009 - Journal of Law, Medicine and Ethics 37 (2):173-175.

Add more citations

References found in this work

No references found.

Add more references